Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 13/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5382343 | 1.00 | DNM1 (0.46) | DNM1KCNH2PLA2G1BPLA2G2ATSHR | |
| SCHEMBL9827794 | 0.97 | KCNH2 (0.42) | DNM1KCNH2PLA2G1BPLA2G2ATSHR | |
| SCHEMBL8374761 | 0.90 | DNM1 (0.50) | DNM1KCNH2PLA2G1BPLA2G2ATSHR | |
| SCHEMBL8375333 | 0.90 | DNM1 (0.50) | DNM1KCNH2PLA2G1BPLA2G2ATSHR | |
| SCHEMBL8375294 | 0.90 | DNM1 (0.50) | DNM1KCNH2PLA2G1BPLA2G2ATSHR | |
| SCHEMBL8379915 | 0.90 | DNM1 (0.50) | DNM1KCNH2PLA2G1BPLA2G2ATSHR | |
| SCHEMBL3248572 | 0.90 | DNM1 (0.50) | DNM1KCNH2PLA2G1BPLA2G2ATSHR | |
| SCHEMBL290988 | 0.90 | DNM1 (0.50) | DNM1KCNH2PLA2G1BPLA2G2ATSHR | |
| SCHEMBL2976163 | 0.90 | — | — | |
| SCHEMBL8376140 | 0.90 | DNM1 (0.50) | DNM1KCNH2PLA2G1BPLA2G2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9874829-B2 | Dispersant for liquid development, liquid developer, liquid developer cartridge, image forming apparatus, and image forming method | FUJI XEROX CO., LTD. (JP) | 2018-01-23 | — | — | US | disclosed |
| US-9822201-B2 | Reflective particle, particle dispersion liquid, display medium, and display device | FUJIFILM CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20170277055-A1 | DISPERSANT FOR LIQUID DEVELOPMENT, LIQUID DEVELOPER, LIQUID DEVELOPER CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJI XEROX CO., LTD. (JP) | 2017-09-28 | — | — | US | disclosed |
| US-9671667-B2 | Electrophoretic particle, electrophoretic particle dispersion liquid, display medium, and display device | E INK CORPORATION (US) | 2017-06-06 | — | — | US | disclosed |
| US-20150353661-A1 | REFLECTIVE PARTICLE, PARTICLE DISPERSION LIQUID, DISPLAY MEDIUM, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2015-12-10 | — | — | US | disclosed |
| US-9152005-B2 | Particle dispersion for display, display medium, and display device | FUJI XEROX CO., LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-9145497-B2 | Colorant-containing particles, colorant-containing particle dispersion, and polymer compound | FUJIFILM CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-9030729-B2 | Particles for display, particle dispersion for display, display medium, and display device | FUJI XEROX CO., LTD. (JP) | 2015-05-12 | — | — | US | disclosed |
| US-20140240815-A1 | PARTICLES FOR DISPLAY, PARTICLE DISPERSION FOR DISPLAY, DISPLAY MEDIUM, AND DISPLAY DEVICE | FUJI XEROX CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
| US-20140240814-A1 | ELECTROPHORETIC PARTICLE, ELECTROPHORETIC PARTICLE DISPERSION LIQUID, DISPLAY MEDIUM, AND DISPLAY DEVICE | FUJI XEROX CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
| EP-1399408-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AG (DE) | 2006-03-22 | — | — | EP | disclosed |
| EP-1583733-A1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | Röhm GmbH & Co. KG (DE) | 2005-10-12 | — | — | EP | disclosed |
| US-20040171868-A1 | Method for producing (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-02 | — | — | US | disclosed |
| CN-1525953-A | Method for producing (meth) acrylic acid esters | �����ɷ� | 2004-09-01 | — | — | CN | disclosed |
| US-20040158096-A1 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-12 | — | — | US | disclosed |
| WO-2004063140-A1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | Röhm GmbH & Co. KG (DE) | 2004-07-29 | — | — | WO | disclosed |
| EP-1399409-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-24 | — | — | EP | disclosed |
| EP-1399408-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002100815-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | WO | disclosed |
| WO-2002100814-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171868-A1 | Method for producing (meth) acrylic acid esters | ADH1A, ADH5, ADH1C | DNM1 1568/4885KCNH2 4056/4885PLA2G1B 2587/4885 |
| US-20040158096-A1 | Method for producing (meth)acrylic acid esters | ADH1A, ADH5, ADH1C | DNM1 2335/4885KCNH2 4099/4885PLA2G1B 2652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.